Which trials will have the greatest impact at TCT 2024?

Get a head start on the biggest cardiovascular breakthroughs of TCT 24! Leading experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) offer an exclusive preview of the most anticipated late-breaking studies set to be unveiled at TCT Conference 2024. Discover their in-depth analysis of these studies and gain invaluable insights ahead of the curve.

TCT Conference 2024 Hot line Trials Included:
ECLIPSE (00:31)
FAVOR III (03:38)
FLASH (05:48)
DCB-BIF (08:04)
CONFIRM II (10:55)
EVOLVE (14:02)
TAVR UNLOAD (20:29)
PEERLESS II (22:29)
TRISCEND II (25:32)
ACCESS TAVI (27:46)
ALIGN AR (30:32)
CLEAR SYNERGY (32:14)
Co-STAR (35:31)

Stay tuned for Radcliffe Cardiology's in-depth coverage of these and other pivotal trials from TCT Conference 2024.